(720 ILCS 570/209) (from Ch. 56 1/2, par. 1209)
    Sec. 209. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule IV if it finds that:
        (1) the substance has a low potential for abuse relative to substances in Schedule III;
        (2) the substance has currently accepted medical use in treatment in the United States;
    
and
        (3) abuse of the substance may lead to limited physiological dependence or psychological
    
dependence relative to the substances in Schedule III.
(Source: P.A. 97-334, eff. 1-1-12.)